Bone Therapeutics S.A   Report issue

For profit Phase 2 Phase 3
Founded: Gosselies Hainaut Belgium (2006)

Organization Overview

First Clinical Trial
2006
NCT02890537
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Bone Therapeutics S.A